Achieve Life Sciences Inc (SP4P) - Total Liabilities

Latest as of December 2025: €20.27 Million EUR ≈ $23.70 Million USD

Based on the latest financial reports, Achieve Life Sciences Inc (SP4P) has total liabilities worth €20.27 Million EUR (≈ $23.70 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Achieve Life Sciences Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Achieve Life Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. See SP4P current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Achieve Life Sciences Inc Competitors by Total Liabilities

The table below lists competitors of Achieve Life Sciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
HANGZHOU TIGERMED CO. H 1 F:5HZ1	Germany	€4.24 Billion
Prothena Corporation plc NASDAQ:PRTA	USA	$57.64 Million
The Anup Engineering Limited NSE:ANUP	India	Rs3.61 Billion
Tianjin Binhai Energy & Development Co Ltd SHE:000695	China	CN¥3.28 Billion
Fenix Outdoor International AG ST:FOI-B	Sweden	Skr340.00 Million
Bright Oceans Inter Telecom Corp SHG:600289	China	CN¥617.06 Million
Carter Bank and Trust NASDAQ:CARE	USA	$4.43 Billion
Huatian Hotel Group Co Ltd SHE:000428	China	CN¥3.65 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Achieve Life Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Achieve Life Sciences Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.94	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.49	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Achieve Life Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Achieve Life Sciences Inc (2016–2025)

The table below shows the annual total liabilities of Achieve Life Sciences Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€20.27 Million ≈ $23.70 Million	+14.31%
2024-12-31	€17.73 Million ≈ $20.73 Million	-14.82%
2023-12-31	€20.82 Million ≈ $24.34 Million	-3.92%
2022-12-31	€21.67 Million ≈ $25.33 Million	+11.27%
2021-12-31	€19.47 Million ≈ $22.77 Million	+546.55%
2020-12-31	€3.01 Million ≈ $3.52 Million	-0.53%
2019-12-31	€3.03 Million ≈ $3.54 Million	-7.74%
2018-12-31	€3.28 Million ≈ $3.84 Million	+63.04%
2017-12-31	€2.01 Million ≈ $2.35 Million	-76.33%
2016-12-31	€8.50 Million ≈ $9.94 Million	--

About Achieve Life Sciences Inc

F:SP4P Germany Biotechnology

Market Cap

$511.28 Million

€437.33 Million EUR

Market Cap Rank

#12613 Global

#1343 in Germany

Share Price

€4.26

Change (1 day)

-10.13%

52-Week Range

€1.79 - €5.05

All Time High

€5709.00